Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11029323 | Lung Cancer | 2018 | 24 Pages |
Abstract
We identified autoantibodies against CTAs in the plasma of lung cancer patients. The reactivity pattern of autoantibodies was higher in cancer patients compared to the benign group, stable over time, but low in frequency of occurrence. The findings suggest that some CTAs are immunogenic and that these properties can be utilized as immune targets.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Dijana Djureinovic, Tea Dodig-CrnkoviÄ, Cecilia Hellström, Georg Holgersson, Michael Bergqvist, Johanna S.M. Mattsson, Fredrik Pontén, Elisabeth StÃ¥hle, Jochen M. Schwenk, Patrick Micke,